Zeon Corporation, through its subsidiary Zeon Ventures, which operates the company’s corporate venture capital activities, has invested in Kanvas Biosciences, a drug‑development company based in Princeton, New Jersey, that leverages the gut microbiome. Through this investment, Zeon aims to pursue new business opportunities related to this field. Kanvas Biosciences is the world’s first drug‑discovery startup engaged in both the development…
